Sign in
TerminatedNo phase

Exoskeleton Variability Optimization

Key facts

Who runs it
University of Nebraska
Where
Omaha, United StatesSee the site
Trial code
Status
Terminated
People taking part
9 people enrolled
Started
31 Jan 2022
Ended
28 Mar 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Exoskeleton Optimization
  • Endurance Evaluation
Record updated
19 June 2025
Why it stopped
The second arm was not completed since the first arm was not successful based on the convergence criteria.

Who can take part

Age
19 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Ability to provide written consent
  • Chronic claudication history
  • Ankle-brachial index < 0.90 at rest
  • Stable blood pressure, lipids, and diabetes for > 6 weeks
  • Ability to walk on a treadmill for multiple five-minute spans
  • Ability to fit in exoskeleton; Waist circumference 78 to 92 centimeters (31 to 36 inches); Thigh circumference 48 to 60 centimeters (19 to 24 inches); Minimal thigh length 28 centimeters (11 inches)

Who cannot take part

  • Resting pain or tissue loss due to peripheral artery disease (PAD, Fontaine stage III and IV)
  • Acute lower extremity event secondary to thromboembolic disease or acute trauma
  • Walking capacity limited by diseases unrelated to PAD, such as:; Neurological disorders; Musculoskeletal disorders (arthritis, scoliosis, stroke, spinal injury, etc.); History of ankle instability; Knee injury; Diagnosed joint laxity; Lower limb injury; Surgery within the past 12 months; Joint replacement; Pulmonary disease or breathing disorders; Cardiovascular disease; Vestibular disorder
  • Current illness
  • Foot ulceration
  • Acute injury or pain in lower extremity
  • Inability to follow visual cues due to blindness
  • Inability to follow auditory cues due to deafness
  • Pregnant

Where in United States

  • University of Nebraska OmahaOmaha, United States

About the trial

What the trial wants to find out

Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. In this study, investigators intend to develop and evaluate HITL optimization methods for exoskeletons and use the information to design and evaluate a portable hip exoskeleton. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD.

The 2 groups in the trial

  • Optimal Assistance PatternTreatment being tested

    An optimization algorithm will change the assistance pattern on the hip exoskeleton during walking sessions and the optimal assistance pattern will be determined when gait variability is minimized.

    Treatment: Exoskeleton Optimization

  • Endurance EffectdsTreatment being tested

    Endurance of participants using ground reaction force (Bertec treadmill), walking speed (Bertec treadmill), indirect calorimetry (Cosmed), and motion capture (Vicon) will be determined.

    Treatment: Endurance Evaluation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exoskeleton Variability Optimization for Reducing Gait Variability for Patients With Peripheral Artery Disease
Record updated
19 June 2025